The study highlighted the biosynthetic potential of Streptomyces chrestomyceticus B5, which is a promising strain for producing various bioactive metabolites and is rich in biosynthetic gene clusters responsible for encoding multiple metabolites and producing an antifungal compound, a streptimidone derivative or isomer, active against drug-resistant Candida auris.
Kumari et al. (Mon,) studied this question.